FirstCash Holdings, Inc. (FCFS)

FirstCash Holdings, Inc. shares are trading at $184.00 after a sharp drop following its October 22, 2026 earnings report, when the stock fell 14.75% in the first session even though adjusted EPS of $2.68 beat the $2.63 estimate by 1.90%. The reaction has left the stock below its 50-day and 200-day moving averages ($207.93 and $207.17) and in the bearish zone on momentum, even as revenue growth and analyst support remain strong. For investors the question is whether the business's growth can reassert itself against a share price that has been repriced lower.

The stock beat on earnings but fell sharply anyway. Adjusted EPS of $2.68 came in above the $2.63 estimate, a beat of 1.90%, yet the share price dropped 14.75% in the first trading session after the October 22, 2026 report. That was the largest one-day reaction in the recent record apart from a 9.12% gain after the April 24, 2025 report. The beat itself was not the whole story. A strong quarter on the earnings line has therefore not guaranteed a higher price, and the October reaction shows how sharply the stock can move when expectations are already high.

Revenue grew 25.73% in the latest quarter year on year, against a sector median of 11.7%, and the company's return on equity of 18.18% is above the sector median of 13.8%. Its net profit margin is 9.48% and its operating margin is 16.11%. The company's health score is 4 of 5 on profitability, balance sheet and growth. The debt-to-equity ratio of 1.24 is the one figure to watch, though for a pawn lender it is read alongside the business model.

At a trailing P/E of 20.34, the stock trades at a premium to the sector median P/E of 16.5, a gap of 23.2%. On price-to-sales it is cheaper than peers, at 1.84 against a sector median of 3.8. The shares are 11.51% below the 50-day SMA and 11.18% below the 200-day SMA, and the one-month return is down 14.89%. The one-year return is up 13.22%, so the longer view is still positive.

Insiders sold $37.8M of stock over the last 18 months across 25 sales, and made no open-market purchases in that period. The sales may have been planned or tied to tax on vesting shares, so they are a weaker signal than purchases would be, but the absence of insider buying during the decline is a fact investors weigh.

The base case is that FCFS trades in a range while the market tests whether earnings growth holds up. Revenue grew 25.73% in the latest quarter year on year, and analysts expect EPS to rise 25.4% this fiscal year to $10.98 and 16.0% next year to $12.75, so the earnings path is the main support. A recovery toward the analysts' median 12-month target of $250.00 would need the price to reclaim the 20-day EMA at $192.90 and then the 200-day SMA at $207.17, which would show that the post-earnings selling is fading. The downside case is that the stock keeps trading below its moving averages and the 52-week low of $146.95 comes back into view, especially if future reports beat estimates but still see the shares fall as they did in October. Analyst targets range from $235.00 to $255.00, all above the current price, but these are analysts' forecasts rather than outcomes.

Support sits at the 52-week low of $146.95, the nearest level below the price and the floor of the stock's one-year range. Resistance comes first from the 20-day EMA at $192.90, which the price has not yet regained, then the 200-day SMA at $207.17 and the 50-day SMA at $207.93, which sit close together and would form a combined hurdle. The 52-week high of $238.93 is the furthest level above the price.